What is Infliximab-dyyb?

Category: Prescription Drugs

Most popular types: Inflectra


Infliximab-dyyb is a medication that is considered biosimilar to infliximab, a monoclonal antibody used in the treatment of a number of autoimmune conditions, including: Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis.


Based on patients currently taking Infliximab-dyyb

Dosage Patients
100mg as needed 1


Currently taking Infliximab-dyyb

Duration Patients
1 - 6 months 1

What people switch to and from

Patients started taking Infliximab-dyyb after stopping:

Treatment Patients
Vedolizumab (Entyvio) 1
Last updated:
There are no evaluations for Infliximab-dyyb.